Concepedia
Statistics
Publications
78
Citations
9K
H-Index
42
Active since
1987
Affiliations
Stanford University(Current)
AstraZeneca (United States)
University of California, Los Angeles
West Los Angeles College
United States Food and Drug Administration
Philip T. Sager is an author at Stanford University specializing in pharmacology, medicine, and cardiology.
Publications per year
1987–2023
Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.
William G. Stevenson, Hafiza Khan, Philip T. Sager et al. · Circulation · 1993 · 903 citations
Medicine, Cardiology, Electrical Engineering +17
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
Christie M. Ballantyne, John Houri, A Notarbartoló et al. · Circulation · 2003 · 682 citations
Pharmacy, Pharmacology, Pharmacotherapy +13
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager, Gary A. Gintant, J. Rick Turner et al. · American Heart Journal · 2013 · 548 citations · Full text
Medicine, Cardiology, Pharmacology +15
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy
Ronald G. Schwartz, W. Mckenzie, J. Steven Alexander et al. · The American Journal of Medicine · 1987 · 512 citations
Medicine, Cardiology, Pharmacology +16
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
Thomas Colatsky, Bernard Fermini, Gary A. Gintant et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 463 citations · Full text
Medicine, Cardiology, Pharmacology +17
1–5 of 78